The CRCHUM at a glance

Université de Montréal's affiliated hospital research centre, the CRCHUM, is one of North America’s leading hospital research centres.

Here, basic, clinical and population health research are carried out side-by-side under one roof.

The Fonds de recherche du Québec — Santé, the provincial body responsible for funding research facilities, confirmed the CRCHUM’s standing as a major Canadian research institution by awarding it an “exceptional” rating in its 2020-2026 strategic plan.

A seat of internationally renowned scientific research, the CRCHUM’s research is rooted in its dynamic community and offers a diversified, fair and inclusive environment for the training of scientists who will leave their marks on the world stage of research tomorrow.

Duration: 1:25

Integrated into all the CHUM’s hospital activities, the Research Centre’s teams count on competitive infrastructure and state-of-the-art technological core facilities to improve the health of the adults of Quebec.

The CRCHUM’s proximity to the university hospital makes it an intellectually rich and stimulating environment, conducive to scientific collaboration and the emergence of internationally recognized achievements and discoveries.

For its day-to-day operations, the CRCHUM can count on the Fondation du CHUM. The Fondation helps fund the purchase of state-of-the-art equipment and contributes to the training of exceptional young researchers and the transfer of the Centre’s unique knowledge.
A global leader in the improvement of health care and services and the patient experience, research at the CRCHUM falls into six main themes:
With its Unit for Innovative Therapies, the CRCHUM is on the front lines of early clinical research. Its goal: to offer patients who have run out of treatment options the most advanced therapies available in oncology, neurology and immunopathology.

This 16-bed unit relies on a team of 35 people and more than 70 investigators to conduct phase 1 and 2 clinical trials. More than 55 clinical trials have been launched there since its opening in the fall of 2018, including several in collaboration with pharmaceutical companies.
For the teams at the CRCHUM, knowledge management is a priority activity. They harness knowledge and identify research results that will materialize in the form of innovations that benefit patients and the health system.

With its Centre for the Integration and Analysis of Medical Data, also known as CITADEL, the CHUM and the CRCHUM rely on their expertise in health data science to make good use of the nearly four million pieces of patient clinical administrative data.*

Thanks to their analyses, the CITADEL team has already allowed more than 120 projects to improve population health.

_*The CHUM and the CRCHUM attach utmost importance to the protection of privacy, the confidentiality of data and access to data. For more information, visit the CITADEL management framework on our website.

Mission

The CRCHUM improves the health of adults through a high-quality academic research continuum which, by furthering our understanding of etiological and pathogenic mechanisms, fosters the development, implementation and assessment of new preventive, diagnostic and therapeutic strategies.

CRCHUM provides a training environment to ensure the development of new generations of researchers committed to research excellence.

Vision

The CRCHUM seeks to attain the highest standards of excellence in the development of new knowledge, in line with the hospital's mission. As one of the hospital's department, the CRCHUM seeks to play a major role in improving health care and health promotion. It fosters interdisciplinary exchanges and harmonizes laboratory research collaborations with patients and the population with a view to promoting health.

In figures*

160 principal scientists

335 investigators

≈530 graduate students and postdoctoral fellows

1043 research and administrative staff
>$150M in research revenues

34 research chairs, including 11 Canada research chairs

≈1272 peer-reviewed publications

339 clinical or epidemiological trials underway
2 research buildings with an area of 48 000 m2

75 basic research laboratories

19 core facilities + 1 pharmacy

1 cyclotron

* Data as of March 31, 2024

En images

Make a donation